Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Non-cash Items (2020 - 2025)

Bolt Biotherapeutics (BOLT) has disclosed Non-cash Items for 5 consecutive years, with $354334.0 as the latest value for Q4 2025.

  • Quarterly Non-cash Items changed N/A to $354334.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $354334.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $354334.0 for FY2025, 94.45% down from the prior year.
  • Non-cash Items hit $354334.0 in Q4 2025 for Bolt Biotherapeutics, up from $12000.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $6.1 million in Q4 2021 to a low of $12000.0 in Q4 2023.
  • Historically, Non-cash Items has averaged $2.4 million across 4 years, with a median of $1.8 million in 2022.
  • Biggest five-year swings in Non-cash Items: rose 28.68% in 2021 and later plummeted 99.64% in 2023.
  • Year by year, Non-cash Items stood at $6.1 million in 2021, then tumbled by 45.02% to $3.3 million in 2022, then tumbled by 99.64% to $12000.0 in 2023, then skyrocketed by 2852.78% to $354334.0 in 2025.
  • Business Quant data shows Non-cash Items for BOLT at $354334.0 in Q4 2025, $12000.0 in Q4 2023, and $3.3 million in Q4 2022.